Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.09B |
| 2 |
Microsoft
MSFT
|
+$349M |
| 3 |
Amazon
AMZN
|
+$322M |
| 4 |
PTC
PTC
|
+$321M |
| 5 |
Intuit
INTU
|
+$314M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$588M |
| 3 |
Linde
LIN
|
+$564M |
| 4 |
NVIDIA
NVDA
|
+$526M |
| 5 |
Salesforce
CRM
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 11.16% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Teva Pharmaceuticals
TEVA
$40.4B
| $91.7M | 0.05% |
6,078,241
-659,384
| -10% | -$11.8M |
|
277
SPX Corp
SPXC
$9.39B
| $90.9M | 0.05% |
702,199
-21,509
| -3% | -$3.08M |
|
278
Rhythm Pharmaceuticals
RYTM
$7.31B
| $90.7M | 0.05% |
1,655,350
+435,796
| +36% | +$24.2M |
|
279
Alight
ALIT
$534M
| $89.6M | 0.05% |
756,699
-124,530
| -14% | -$16.4M |
|
280
Neurocrine Biosciences
NBIX
$18.2B
| $88.7M | 0.05% |
783,966
-10,152
| -1% | -$1.29M |
|
281
Saia
SAIA
$10.5B
| $88.3M | 0.05% |
245,957
+35,810
| +17% | +$15.6M |
|
282
Roper Technologies
ROP
$40.4B
| $87.1M | 0.05% |
149,546
+35,667
| +31% | +$20M |
|
|
CNTA
283
DELISTED
Centessa Pharmaceuticals
CNTA
| $86.4M | 0.05% |
5,922,486
+1,012,999
| +21% | +$16.6M |
|
284
Structure Therapeutics
GPCR
$3.37B
| $86.1M | 0.05% |
4,355,194
+195,306
| +5% | +$4.78M |
|
285
CACI
CACI
$10.8B
| $85.5M | 0.05% |
228,916
+32,532
| +17% | +$12.4M |
|
286
AST SpaceMobile
ASTS
$15.8B
| $84.4M | 0.05% |
3,509,630
-126,081
| -3% | -$3.22M |
|
287
Doximity
DOCS
$3.89B
| $84.2M | 0.05% |
1,439,531
-702,947
| -33% | -$44.4M |
|
288
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $82.5M | 0.05% |
1,650,687
+531,979
| +48% | +$26.6M |
|
289
nVent Electric
NVT
$21.6B
| $81.9M | 0.04% |
1,548,882
+265,445
| +21% | +$16.8M |
|
290
Gilead Sciences
GILD
$165B
| $81.4M | 0.04% |
728,417
-567,660
| -44% | -$58.6M |
|
|
MTSR
291
DELISTED
Metsera Inc
MTSR
| $81.3M | 0.04% |
+2,905,462
| New | +$82.4M |
|
292
Universal Display
OLED
$3.75B
| $80M | 0.04% |
550,925
-748
| -0.1% | -$112K |
|
293
CBRE Group
CBRE
$43.3B
| $79.9M | 0.04% |
617,415
+71,226
| +13% | +$9.68M |
|
294
Silgan Holdings
SLGN
$4.51B
| $79.7M | 0.04% |
1,570,866
+55,284
| +4% | +$2.9M |
|
295
Bank of America
BAC
$429B
| $79.5M | 0.04% |
1,926,712
+203,682
| +12% | +$9.08M |
|
296
FirstService
FSV
$6.55B
| $79.4M | 0.04% |
478,046
+361,517
| +310% | +$63.3M |
|
297
Sotera Health
SHC
$5B
| $78.9M | 0.04% |
6,703,110
-1,079,452
| -14% | -$13.9M |
|
298
Donaldson
DCI
$10.7B
| $78.8M | 0.04% |
1,174,326
-122,903
| -9% | -$8.5M |
|
299
Liberty Media Series A
FWONA
$23.4B
| $77.3M | 0.04% |
962,241
+13,334
| +1% | +$1.13M |
|
300
Stantec
STN
$8.17B
| $77.2M | 0.04% |
932,630
+223,524
| +32% | +$17.9M |
|
Similar funds
Janus Henderson Group's Q1 2025 Portfolio in Review
As of Q1 2025, Janus Henderson Group held 2,583 positions worth $182B, down 7.3% from $197B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Janus Henderson Group's Q1 2025 filing shows 59 new, 699 increased, 823 reduced and 102 closed positions. Its largest new stake was Metsera Inc: 2,905,462 shares worth $81.3M. The largest sale was Meta Platforms (Facebook), an estimated $602M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2025 buy was Metsera Inc: 2,905,462 shares worth $81.3M.
- Janus Henderson Group added most to Broadcom in Q1 2025, an estimated $1.09B increase.
- Janus Henderson Group's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $602M.
- Janus Henderson Group fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 31% of its $182B portfolio in Q1 2025.
- Janus Henderson Group opened 59 new positions and closed 102 in Q1 2025.
- Janus Henderson Group's portfolio value fell 7.3% quarter-over-quarter to $182B.
Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.